| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.004 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |